Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia	Malignant Solid Tumors	Recruiting	Phase 2	2026-09-23		NCT06629584

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
M.D. Anderson Cancer Center	1145
Novartis	114

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The University of Texas MD Anderson Cancer Center	Houston	United States	207

Clinical trials